ArticleMolecules (Basel, Switzerland)2022

Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell Lung Cancer.

Yingqing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.